Portfolio News
Sofinnova Crossover & Sofinnova Industrial Biotech
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Related Company
SynthaceRelated Strategy
CrossoverRelated Strategy
Industrial BiotechRelated Deal lead
Joško BobanovićRelated News
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease
HAYA Therapeutics receives FDA Fast Track Designation for HTX-001
Moon Surgical and KARL STORZ Announce Strategic Commercial Collaboration to Advance Scalable Surgery
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline